Chamber and committees

The Scottish Government does not centrally collect information or data relating to the use of Do Not Attempt Cardiovascular Resuscitation (DNACPR) forms in hospitals.

As with all other clinical treatments, decisions about CPR should be based on the individual clinical circumstances and wishes of the patient, recorded appropriately and updated when medical circumstances change. This recording is done in hard copy on a DNACPR form, the existence of which is then recorded on an individual’s Key Information Summary. Such information is only shared for the purposes of direct care and is therefore not centrally collected.

Scottish Government does not yet hold this data for 2021-22. We have asked for this information as part of routine monitoring of implementation of the Young Patient’s Family Fund, from Health Boards.

The Chief Scientist Office (CSO) provides funding to support and facilitate high quality applied research across a wide health and care remit

CSO Approach to Funding – Chief Scientist Office (scot.nhs.uk)

This includes funding in support of research in areas of public health, or health and care where delivery may be outside of clinical settings

CSO's annual budget from 2012-13 to 2022-23 is provided below:

2012-13 £67.9 million

2013-14 £68.3 million

2014-15 £68.5 million

2015-16 £66.8 million

2016-17 £64.8 million

2017-18 £64.4 million

2018-19 £67.2 million

2019-20 £69.9 million

2020-21 £69.9 million

2021-22 £75.4 million (includes £3.5 million non-recurring COVID-19 funding)

2022-23 £78.4 million

I refer the member to the answer to PQ S6W-08047 on 10 May 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Young Patients Family Fund provides valuable financial support to eligible visitors of inpatients up to the age of 18. There are currently no plans to extend the age range.

Those aged between 18 – 25 years old continue to have access to the Patient Travel Expenses Scheme or the Highlands and Islands Travel Scheme, both of which provide eligible claimants with support to meet travel costs associated with outpatient appointments.

The Young Patients Family Fund provides valuable financial support to eligible visitors of inpatients up to the age of 18 who are being treated in Scotland.

We recognise it is not possible to deliver all services and treatments in all locations. That is why, where patients are required to travel we already expect boards to take a patient centred approach and to have in place arrangements to allow and support people to receive treatment elsewhere. In addition, financial support for travel is available for patients and authorised escorts attending hospital appointments, in line with eligibility criteria and medical requirements.

We are committed to ensuring that alcohol treatment in Scotland is consistent and of high quality. We are supporting the Office for Health Improvement and Disparities, which has been leading on the development of new UK-wide clinical guidelines for alcohol treatment.

We expect the draft guidance to be published for consultation this year. We will work with our partners to ensure that it is suitable for Scotland and how the guidance could be implemented effectively and consistently across the country.

The forthcoming UK clinical guidelines will act as a platform to develop alcohol specific treatment targets. The intention would be that these would launch in 2024.

In its first year of operation, a total of £2,056,179 was paid out to Scotland’s 14 territorial Health Boards for the Young Patients Family Fund in 2021-22.

Scottish Government does not yet hold data on how many individual people have benefitted so far.

The Young Patients Family Fund provides valuable financial support to eligible visitors of inpatients up to the age of 18. There are currently no plans to extend eligibility for outpatient treatment.

These are the directly funded clinical academic fellowships (CAF) and Senior Clinical Academic Fellowships (SCAF) awarded by the Chief Scientist Office since 2012.